Oncolys BioPharma Inc.

¥7,400As of Sun 8 Nov 2026, 12:00 UTC
TSE:4588Healthcare
Country Japan
PE (Fwd) •••
TSR 10Y CAGR 22.10%
Div yield —
ROE (110.09%)
Biotechnology
Beta (5Y) 1.13
PE TTM —
TSR TTM 889.30%
Mkt cap ¥218.7B
ROIC (345.38%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
¥7,729
4.44%
(90.96%)
Hold 6|4|5|5|1
4Q25
1Q26
2Q26
3Q26
Earnings per share¥
95.47
105.66
105.89
114.64
9.18%
13.60%
16.82%
17.92%
Revenue¥B
13.74
13.91
13.93
14.03
12.44%
7.78%
8.67%
6.14%
Peers (US$1.388B)
Cap (US$)
PE
866.6M
—
848.1M
—
1.389B
6.637x
Capital
TTM
5Y
10Y
Leveragex
1.950
0.031
0.029
EBIT/Intx
0.864
0.828
0.844
Own earn%
61.76
(28.66)
(39.12)
Sh yield%
14.06
26.01
23.63
Owners
Insiders/Inst%
3.17
57.40
Short interest%
3.47
SBC / revenue%
1.07
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
23
Op margin range%
0–5
$1 testx
0.0
Incr. ROIC%
13